Benlysta 200 MG/ML autoinjectml
Ended Awarded
- Contract number
- SPE2DB25FY9FU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,661
Award facts
- Contract value 100% obligated
- $24,661.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $24,661.36 to AmerisourceBergen Drug Corp for BENLYSTA 200 mg/ml auto-injector units on August 12, 2025, with completion targeted for September 3, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. BENLYSTA (belimumab) is a monoclonal antibody indicated for treating systemic lupus erythematosus and is part of the broader pharmaceutical supply portfolio that DLA maintains for military and federal healthcare systems.
This delivery order operates as a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies an extensive range of brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally. The company's selection reflects its demonstrated capability to meet federal procurement requirements through open competition and its significant role within DLA's pharmaceutical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DB25FY9FU?
SPE2DB25FY9FU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 12, 2025.
How much is contract SPE2DB25FY9FU worth?
The government has obligated $24,661 on SPE2DB25FY9FU.
Is contract SPE2DB25FY9FU an order under another contract?
Yes. SPE2DB25FY9FU is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FY9FU competed?
The extent of competition for SPE2DB25FY9FU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award